Get started
Author

Chantaratsamon Dansirikul

Observed names: C. DANSIRIKUL, C. Dansirikul, Chantaratsamon. Dansirikul
OpenAlex ID: A5030951691
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial
2011 · K.‐H. LIESENFELD, T. LEHR, et al. · Journal of Thrombosis and Haemostasis · 305
PDF
Approaches to handling pharmacodynamic baseline responses
2008 · Chantaratsamon Dansirikul, Hanna E. Silber, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 80
A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgery
2012 · Thorsten Lehr, Karl-Heinz Liesenfeld, et al. · Thrombosis and Haemostasis · 48
A Bayesian approach for population pharmacokinetic modelling of sirolimus
2005 · Chantaratsamon Dansirikul, Raymond G. Morris, et al. · British Journal of Clinical Pharmacology · 41
Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel®
2004 · Chantaratsamon Dansirikul, Malcolm Choi, et al. · Computers in Biology and Medicine · 37
A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers
2017 · Katja Boland, Viktoria Moschetti, et al. · Human Psychopharmacology Clinical and Experimental · 28
Sampling Times for Monitoring Tacrolimus in Stable Adult Liver Transplant Recipients
2004 · Chantaratsamon Dansirikul, Christine E. Staatz, et al. · Therapeutic Drug Monitoring · 25
Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients
2005 · C. Dansirikul, S. B. Duffull, et al. · British Journal of Clinical Pharmacology · 9
Bayesian Hierarchical Modeling with Markov Chain Monte Carlo Methods
2006 · Stephen B. Duffull, Lena E. Friberg, et al. · Pharmacometrics · 8
Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients
2006 · C. Dansirikul, C. E. Staatz, et al. · Journal of Clinical Pharmacy and Therapeutics · 7
PDF
A Semi‐Physiological Model of Amyloid‐β Biosynthesis and Clearance in Human Cerebrospinal Fluid: A Tool for Alzheimer's Disease Research and Drug Development
2013 · Karin G. Haug, Alexander Staab, et al. · The Journal of Clinical Pharmacology · 3
Simultaneous fit of competing models as a model discrimination tool in Bayesian analysis
2004 · Lena E. Friberg, C. Dansirikul, et al. · 3
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial: reply to a rebuttal
2011 · K.‐H. LIESENFELD, T. LEHR, et al. · Journal of Thrombosis and Haemostasis · 1
The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study
2022 · Fabian Müller, Michael Sand, et al. · European Journal of Clinical Pharmacology
PDF
Pharmacokinetic studies with sirolimus and tacrolimus
2004 · Chantaratsamon. Dansirikul · The University of Queensland
Bayesian population pharmacokinetic analysis of sirolimus
2004 · C. Dansirikul, Lena E. Friberg, et al.
An argument for dose individualisation of sirolimus in renal transplant recipients
2004 · C. Dansirikul, Stephen B. Duffull, et al. · Clinical and Experimental Pharmacology and Physiology
Limited sampling strategies for monitoring tacrolimus in liver transplant recipients
2003 · C. Dansirikul, Christine E. Staatz, et al.
Conversion of non-compartmental to compartmental pharmacokinetics: Proof of concept study
2002 · C. Dansirikul, Mina Choi, et al.
Abbreviated AUC for monitoring tacrolimus in liver transplant recipients
2002 · C. Dansirikul, Christine E. Staatz, et al.
Works count: 21
Citation count: 595
H-index: 8
I10-index: 7
Year
Topic
Type